Kymera Therapeutics Inc (KYMR) earnings · rev $39.2M
These earnings events as JSON? API free 100/dayKymera Therapeutics Inc (KYMR) is a biotechnology company listed on NASDAQ.
This KYMR earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported KYMR revenue for 2025-12-31 was $39.2M. Net income was -$311.4M. Revenue was down 16.7% from 2024-12-31 to 2025-12-31. KYMR currently screens at market cap $7.39B.
When the next KYMR 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 16.7% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full KYMR research stays on the stock page; the tape stays on the quote page.
KYMR earnings FAQ
What are KYMR's latest revenue and net income?
Latest cached Kymera Therapeutics Inc (KYMR) revenue for Dec 31, 2025 was $39.2M. Net income was -$311.4M. Statements: https://lician.com/financials/kymr
What is KYMR's latest diluted EPS?
Latest cached Kymera Therapeutics Inc (KYMR) diluted EPS for Dec 31, 2025 was -$3.69.
What period does the latest KYMR earnings print cover?
The latest cached Kymera Therapeutics Inc (KYMR) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did KYMR revenue change from the prior cached period?
Cached Kymera Therapeutics Inc (KYMR) revenue was down 16.7% from $47.1M (Dec 31, 2024) to $39.2M (Dec 31, 2025). Statements: https://lician.com/financials/kymr
Where are KYMR earnings listed?
Cached earnings facts for Kymera Therapeutics Inc (KYMR) are listed at https://lician.com/earnings/kymr. Statements: https://lician.com/financials/kymr
Not investment advice.